Rebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins
The suppressor of T cell receptor signaling (Sts) proteins are negative regulators of immune signaling. Genetic inactivation of these proteins leads to significant resistance to infection. From a 590,000 compound high-throughput screen, we identified the 2-(1H)-quinolinone derivative, rebamipide, as a putative inhibitor of Sts phosphatase activity. Rebamipide, and a small library of derivatives, are competitive, selective inhibitors of Sts-1 with IC50 values from low to submicromolar. SAR analysis indicates that the quinolinone, the acid, and the amide moieties are all essential for activity. A crystal structure confirmed the SAR and reveals key interactions between this class of compound and the protein. Although rebamipide has poor cell permeability, we demonstrated that a liposomal preparation can inactivate the phosphatase activity of Sts-1 in cells. These studies demonstrate that Sts-1 enzyme activity can be pharmacologically inactivated and provide foundational tools and insights for the development of immune-enhancing therapies that target the Sts proteins.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
---|---|
Enthalten in: |
Journal of medicinal chemistry - 67(2024), 3 vom: 08. Feb., Seite 1949-1960 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Aziz, Faisal [VerfasserIn] |
---|
Links: |
---|
Themen: |
4QD397987E |
---|
Anmerkungen: |
Date Completed 09.02.2024 Date Revised 25.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/acs.jmedchem.3c01763 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36743122X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36743122X | ||
003 | DE-627 | ||
005 | 20240425232730.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240123s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acs.jmedchem.3c01763 |2 doi | |
028 | 5 | 2 | |a pubmed24n1386.xml |
035 | |a (DE-627)NLM36743122X | ||
035 | |a (NLM)38252624 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Aziz, Faisal |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.02.2024 | ||
500 | |a Date Revised 25.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The suppressor of T cell receptor signaling (Sts) proteins are negative regulators of immune signaling. Genetic inactivation of these proteins leads to significant resistance to infection. From a 590,000 compound high-throughput screen, we identified the 2-(1H)-quinolinone derivative, rebamipide, as a putative inhibitor of Sts phosphatase activity. Rebamipide, and a small library of derivatives, are competitive, selective inhibitors of Sts-1 with IC50 values from low to submicromolar. SAR analysis indicates that the quinolinone, the acid, and the amide moieties are all essential for activity. A crystal structure confirmed the SAR and reveals key interactions between this class of compound and the protein. Although rebamipide has poor cell permeability, we demonstrated that a liposomal preparation can inactivate the phosphatase activity of Sts-1 in cells. These studies demonstrate that Sts-1 enzyme activity can be pharmacologically inactivated and provide foundational tools and insights for the development of immune-enhancing therapies that target the Sts proteins | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a rebamipide |2 NLM | |
650 | 7 | |a LR583V32ZR |2 NLM | |
650 | 7 | |a Histidine |2 NLM | |
650 | 7 | |a 4QD397987E |2 NLM | |
650 | 7 | |a Receptors, Antigen, T-Cell |2 NLM | |
650 | 7 | |a Quinolones |2 NLM | |
650 | 7 | |a Phosphoric Monoester Hydrolases |2 NLM | |
650 | 7 | |a EC 3.1.3.2 |2 NLM | |
650 | 7 | |a Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Alanine |2 NLM | |
650 | 7 | |a OF5P57N2ZX |2 NLM | |
700 | 1 | |a Reddy, Kanamata |e verfasserin |4 aut | |
700 | 1 | |a Fernandez Vega, Virneliz |e verfasserin |4 aut | |
700 | 1 | |a Dey, Raja |e verfasserin |4 aut | |
700 | 1 | |a Hicks, Katherine A |e verfasserin |4 aut | |
700 | 1 | |a Rao, Sumitha |e verfasserin |4 aut | |
700 | 1 | |a Jordan, Luis Ortiz |e verfasserin |4 aut | |
700 | 1 | |a Smith, Emery |e verfasserin |4 aut | |
700 | 1 | |a Shumate, Justin |e verfasserin |4 aut | |
700 | 1 | |a Scampavia, Louis |e verfasserin |4 aut | |
700 | 1 | |a Carpino, Nicholas |e verfasserin |4 aut | |
700 | 1 | |a Spicer, Timothy P |e verfasserin |4 aut | |
700 | 1 | |a French, Jarrod B |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d 1963 |g 67(2024), 3 vom: 08. Feb., Seite 1949-1960 |w (DE-627)NLM000006602 |x 1520-4804 |7 nnns |
773 | 1 | 8 | |g volume:67 |g year:2024 |g number:3 |g day:08 |g month:02 |g pages:1949-1960 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.jmedchem.3c01763 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 67 |j 2024 |e 3 |b 08 |c 02 |h 1949-1960 |